Federal Circuit reverses jmol of invalidity of Teva’s ajovy® patents JD Supra 16:59 Wed, 06 May JD Supra 16:59 Wed, 06 May Eli Lilly Pharma All sources
Teva signs off $900m Emalex buyout amid strategic pipeline boosting ploy Pharmaceutical Technology 11:27 Thu, 30 Apr Pharmaceutical Technology 11:27 Thu, 30 Apr Emalex Pharma All sources
Teva Pharmaceutical Industries (Teva) reports Q1 earnings: What key metrics have to say Zacks 17:04 Wed, 29 Apr Zacks 17:04 Wed, 29 Apr Emalex Pharma All sources
Teva acquires Emalex Biosciences for up to $900m Globes 13:02 Wed, 29 Apr Globes 13:02 Wed, 29 Apr Pharma
Teva Q1 earnings top estimates, branded drugs drive revenues, stock up Zacks 16:21 Thu, 30 Apr Zacks 16:21 Thu, 30 Apr Pharma
Teva Stock Is at Its Highest Level in Nearly a Decade. Here's Why It Could Soar Even More. The Motley Fool 06:33
Wall Street Thinks Teva Stock Still Has Room to Run After Soaring Over 100%. Here's Why Analysts Are Right. The Motley Fool 10:11 Thu, 14 May
Teva v. Lilly: Conflicting Positions at PTAB and District Court Sink Patent Challenge JD Supra 19:10 Fri, 08 May
Movement Disorder Tardive Dyskinesia Webpage Launched By Nonprofit Rural Minds AgriMarketing 08:03 Thu, 07 May
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally? Simply Wall St 19:01 Tue, 05 May
Two Setups, One Framework: What eBay and Teva Reveal About Trade Selection Barchart 20:28 Sat, 02 May